Shares of Humana Inc. are poised to rebound after a rough performance in 2012, thanks in part to growth prospects for the health insurer's Medicare Advantage plans, according to a Bernstein Research analyst.

The Louisville, Ky., company's stock sank 22 percent last year to close at $68.63. In contrast, the Standard & Poor's 500 index rose more than 13 percent.

Analyst Ana Gupte said in a Thursday morning research note she has a $95 price target on the stock, and she expects 2013 earnings of $9.20 per share, which far exceeds the company's initial forecast for earnings of between $7.60 and $7.80 per share. The insurer expects 2012 earnings of $7.25 to $7.35 per share.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Core and Group Health
Voluntary Benefits
Consumer Driven Health Care